Blog

FDA Approves Elagolix (Orilissa) for Endometriosis Pain

On July 24th, 2018 the US Food and Drug Administration (FDA) approved Elagolix for the treatment of moderate to severe pain associated with endometriosis. Dr. Robin Kroll, director of Seattle Women’s Health Research Gynecology has conducted over a dozen clinical trials with the newly approved endometriosis treatment, Orilissa. The drug, Elagolix — now marketed as

Read More »

“The Little Pink Pill”

This month, Flibanserin, commonly referred to as “female Viagra,” goes to the full Food and Drug Administration for a vote of approval. In early June, a federal advisory committee to the FDA recommended approval. The final vote is due on or before August 18. The entire concept of Female Sexual Dysfunction (FSD) is controversial. Does

Read More »

But What About the HPV Vaccine?!

The Cancer Risk Awareness Survey, conducted by the American Institute for Cancer Research (referenced here), demonstrates that we Americans aren’t always aware of things that have been proven to decrease our risk of cancer, and sometimes do things we think decrease our risk of cancer, but have not been proven to do so. But they neglect to mention a very

Read More »

Patches, Pills, Rings, and Things

Birth control pills were first released in the 1960s, and since then the variety and choice in contraception has only expanded. Picking what’s right for you can be a bit overwhelming and confusing, but at Seattle Women’s we want you to be informed so we’ve put together a brief summary of the popular options and

Read More »